With illegal drug use rising, can a cancer drug be repurposed to cure cocaine addiction?

Not all successful biosimilar applications in Europe follow guidelines to the letter

Why is the pharma industry so despised when it has saved countless lives?

In this article, we take an introductory look at how TDA works, the information it provides and its complementary application to other techniques within the drug development workflow. In addition, example case study data will showcase the performance of TDA relative to dynamic light scattering (DLS) for assessment of the impact of a range of parameters on the monomer-dimer-hexamer equilibrium of insulin.

In this article, triple detection SEC and MDRS are considered within the context of characterizing complex drug formulations, with specific case studies and results illustrating their application.

Mylan introduces new schemes to help tackle EpiPen costs for patients, as well as plans for a new direct-to-patient distribution model

Predicting and measuring protein aggregation is a critical challenge in the formulation of biopharmaceuticals. This article describes an analytical tool that hits the ‘sweet spot’ of protein aggregation measurement

This article explains how dynamic light scattering (DLS) can be used to gather particle size distribution data for the successful use of nanosized colloidal gold in drug delivery applications.

Protection at the genetic level – a new line of defense against contamination in biopharmaceutical manufacturing

Here, Tim Sandle gives a rundown of his top advances in cleanrooms in recent years.